EF CLIF | European Foundation for the study of chronic liver failure
EF CLIF | European Foundation for the study of chronic liver failure
If you need assistance please contact us .
22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis). We aim to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (decompensated cirrhosis), when such decompensated cirrhosis will progress to acute-on-chronic liver failure (ACLF), and a patient’s individual treatment response. Based on such biomarkers, we strive to develop novel diagnosti
Learn more
EF CLIF | European Foundation for the study of chronic liver failure
EF CLIF | European Foundation for the study of chronic liver failure